These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 32722100)

  • 21. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
    Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
    World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia.
    Picca A; Fanelli F; Calvani R; Mulè G; Pesce V; Sisto A; Pantanelli C; Bernabei R; Landi F; Marzetti E
    Mediators Inflamm; 2018; 2018():7026198. PubMed ID: 29686533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link.
    Ryu JY; Choi HM; Yang HI; Kim KS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the gut-liver-immune axis to treat cirrhosis.
    Tranah TH; Edwards LA; Schnabl B; Shawcross DL
    Gut; 2021 May; 70(5):982-994. PubMed ID: 33060124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
    Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
    Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation.
    Martinez-Medina M; Denizot J; Dreux N; Robin F; Billard E; Bonnet R; Darfeuille-Michaud A; Barnich N
    Gut; 2014 Jan; 63(1):116-24. PubMed ID: 23598352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms and consequences of intestinal dysbiosis.
    Weiss GA; Hennet T
    Cell Mol Life Sci; 2017 Aug; 74(16):2959-2977. PubMed ID: 28352996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
    Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
    Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related sarcopenia and altered gut microbiota: A systematic review.
    Wang M; Ren F; Zhou Y; He Y; Du T; Tan Y
    Microb Pathog; 2024 Oct; 195():106850. PubMed ID: 39142365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
    Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
    J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.
    Meyer F; Bannert K; Wiese M; Esau S; Sautter LF; Ehlers L; Aghdassi AA; Metges CC; Garbe LA; Jaster R; Lerch MM; Lamprecht G; Valentini L
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications.
    Chen J; Vitetta L
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
    Woodhouse C; Singanayagam A; Patel VC
    Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia.
    Ponziani FR; Picca A; Marzetti E; Calvani R; Conta G; Del Chierico F; Capuani G; Faccia M; Fianchi F; Funaro B; Josè Coelho-Junior H; Petito V; Rinninella E; Paroni Sterbini F; Reddel S; Vernocchi P; Cristina Mele M; Miccheli A; Putignani L; Sanguinetti M; Pompili M; Gasbarrini A;
    Liver Int; 2021 Jun; 41(6):1320-1334. PubMed ID: 33713524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.